Hantavirus - More Than Just a Mouse Problem: How to Effectively Protect Yourself and Your Family
An Invisible Companion: Why Hantaviruses Concern Us
The news in May 2026 sounded alarming: On the expedition cruise ship “MV Hondius,” which was traveling in the South Atlantic, an outbreak of hantavirus occurred, resulting in three deaths and several other people requiring intensive care. Suddenly, a pathogen that many had not previously known was making headlines.
But the alarm raises questions: Is this a new, exotic threat? The clear answer is: No. Hantaviruses are nothing new, especially not in Germany. They have been observed seasonally here for decades, and the Robert Koch Institute (RKI) and public health authorities have extensive knowledge of how to deal with them. The key to staying calm lies in understanding the routes of transmission and consistently applying simple preventive measures.
Hantaviruses are a textbook example of zoonoses - pathogens that jump from animals to humans. Their history goes back a long way: the first virus in this family was isolated near Korea's Hantaan River in 1976, but Chinese and Russian physicians had described the disease centuries earlier. In Germany, between a few dozen and several thousand cases are recorded each year, with substantial fluctuations depending on weather conditions and the availability of food for rodents. The outbreak on the “MV Hondius” in 2026 was a tragic isolated incident caused by Andes virus (ANDV), which is endemic to South America - the only hantavirus proven to be transmissible from person to person. This article provides the specialist knowledge you need, dispels myths, and offers practical guidance - based on the latest findings from the RKI, the European Centre for Disease Prevention and Control (ECDC), and the World Health Organization (WHO).
The Pathogen in Detail: What Research Knows Today
The Virus Family: A Global Perspective
Hantaviruses (family Hantaviridae, genus Orthohantavirus) are enveloped RNA viruses with a tripartite, single-stranded genome of negative polarity. This genome encodes three main proteins: an RNA polymerase, a nucleocapsid protein, and a glycoprotein precursor that is cleaved into the two envelope proteins Gn and Gc. Unlike humans, the animal hosts - mainly rodents, but also insectivores and bats - do not become ill themselves, but shed the viruses lifelong in high concentrations through saliva, urine, and feces.
The global distribution of hantaviruses follows the distribution of their natural reservoirs. Two clinical syndromes are relevant to humans:
- In Eurasia, including Germany, “Old World hantaviruses” cause hemorrhagic fever with renal syndrome (HFRS). The fatality rate ranges from 1 to 15 percent, depending on the virus type. In Central Europe, a milder form, nephropathia epidemica, predominates.
- In North and South America, “New World hantaviruses” cause hantavirus pulmonary syndrome (HPS) - a severe, often fatal lung disease with a fatality rate of up to 40–50 percent.
In Germany, the Puumala virus (PUUV) is particularly endemic; its reservoir is the bank vole (Myodes glareolus). It is responsible for more than 90 percent of the cases reported here. The Dobrava-Belgrade virus (DOBV), transmitted by the striped field mouse (Apodemus agrarius), also occurs in northeastern Germany. The Seoul virus (SEOV), whose host is the brown rat, is distributed worldwide and has also been detected in Europe. The crucial point is that, according to current knowledge, these virus types found in Germany cannot be transmitted from person to person. An infected person is not contagious to people around them.
The ANDV exception: What makes the outbreak on the “MV Hondius” special
The tragic incident on the cruise ship was caused by the South American Andes virus (ANDV). This virus is unusual for several reasons: It causes the highly dangerous hantavirus pulmonary syndrome, with a fatality rate of up to 50 percent. And it is the only known hantavirus that can, in rare cases, be transmitted from person to person through close and prolonged contact.
Person-to-person transmission was first documented in Argentina in 1996 and has since been confirmed in several outbreaks. Studies show that close and prolonged contact - for example, within the household or when caring for infected people - increases the risk. However, transmission efficiency is low: even among household contacts, the secondary attack rate is only around 2–4 percent. By comparison, this figure was many times higher for COVID-19 before the vaccine era.
In its risk assessment from May 2026, the ECDC emphasizes that the natural reservoir for ANDV is not found in Europe. The establishment of the virus in European rodent populations is therefore not expected. The risk to the general population in the EU from this outbreak is considered very low. Nevertheless, the health authorities in the countries concerned have taken extensive precautionary measures, including a six-week quarantine for all passengers after disembarkation.
Routes of infection and disease progression: What happens in the body
The Invisible Route of Transmission
By far the most common route of infection is inhalation of virus-containing aerosols. The viruses can remain infectious for weeks in dried dust contaminated with rodent excrement - and, at room temperature and low humidity, even for several months. When sweeping an attic, stacking wood in a shed, or even raking leaves in the garden, these particles can be stirred up and inhaled. Infections through direct contact with contaminated surfaces followed by touching the mucous membranes, bites from infected animals, or consumption of contaminated food are much less common but possible.
The risk areas in Germany include, in particular, rural and forest-adjacent regions: the Swabian Jura, the Bavarian Forest, the Franconian Jura, the Odenwald, the Münsterland, and the Teutoburg Forest. Most cases occur seasonally between April and September, when people spend more time outdoors and rodent populations become active after winter dormancy. In years with heavy beech mast - that is, a high abundance of tree seeds - the number of bank voles, and thus the risk of infection, increases significantly.
Symptoms: A deceptive resemblance to the flu
After an incubation period of seven days to six weeks - usually two to four weeks - the disease generally begins suddenly with a high fever, chills, and severe headaches, back pain, and limb pain. Nausea, vomiting, and abdominal pain are also common. These flu-like symptoms are nonspecific, making diagnosis extremely difficult in the early phase. Visual disturbances, particularly acute myopia (nearsightedness), can be a characteristic early symptom of nephropathia epidemica.
In the second phase of the disease - in the types occurring in Germany - the clinical picture shifts toward kidney involvement. Acute kidney dysfunction with reduced urine output (oliguria), high blood pressure, and proteinuria can occur. In severe cases, temporary dialysis is necessary. Hemorrhagic diathesis with a tendency to bleed is rare in PUUV infections but occurs more frequently in DOBV infections. Mortality is below one percent for the European types. The situation is different with American HPS: here, the fever stage is followed by rapidly progressing pulmonary involvement with noncardiogenic pulmonary edema, shortness of breath, and cardiogenic shock, requiring immediate intensive care.
Diagnosis and treatment: What doctors can do
The diagnosis is usually made serologically by detecting specific IgM and IgG antibodies using ELISA or an immunofluorescence test. IgM antibodies can be detected as early as the onset of clinical symptoms. In the very early phase of the disease, the viral genome can be detected directly using PCR, but because the viremic phase is short, this is often possible only for a limited time.
No specific antiviral treatment currently exists. Ribavirin, a broad-spectrum antiviral, has shown some effect in several studies, but it is not routinely recommended because of its side effects and inconsistent study results. Treatment is purely symptomatic: it ranges from fever-reducing and pain-relieving measures (with nonsteroidal anti-inflammatory drugs such as ibuprofen to be avoided because of the strain they place on the kidneys) to close monitoring of kidney function and intensive care with ventilation and dialysis in severe cases. Seeing a doctor as early as possible is crucial, especially if flu-like symptoms occur after a risky activity. The patient should be sure to inform the doctor about possible contact with rodents or their excrement.
Prevention in Practice: Your Shield Against the Virus
Since neither a specific treatment nor an approved vaccine exists, exposure prophylaxis - that is, avoiding contact with the virus - is the only and highly effective protection strategy. It consists of three pillars.
Rodent Management: Denying Carriers Access
The foundation of all prevention is making the human living environment unattractive to mice.
- Seal the building: Check the house, basement, attic, garage, and shed for cracks and gaps around doors, windows, and walls. A hole as thick as a pencil is already enough for a mouse to enter. Seal these openings with concrete, steel wool, or special grilles.
- Eliminate food sources: Store pet food, birdseed, seeds, or supplies in closed, preferably rodent-proof containers. Dispose of food scraps and waste in sealable garbage bins, not in the household compost.
- Clear the surroundings: Remove debris, woodpiles, and brush piles near the house, as these serve as shelter. Keep the immediate area around the house free of dense vegetation. Do not store firewood directly against the exterior wall.
Hygienic Cleaning and Disinfection: The Essential Rules
The highest risk of infection occurs when cleaning rooms where mice have been present. The most dangerous thing you can do is simply sweep with a broom or use a vacuum cleaner. This massively stirs up contaminated dust and disperses it into the air. The ECDC also recommends consistent cleaning and disinfection measures for healthcare workers who come into contact with suspected cases.
Step-by-step guide to safe cleaning:
- Ventilate: Open windows and doors before starting work and ventilate the room thoroughly for at least 30 minutes.
- Put on protective clothing: Put on disposable gloves and a protective mask.
- Dampen, do not sweep: Generously spray visible rodent droppings, dead animals, or nests with a suitable disinfectant. Allow the product sufficient time to work (at least 5-10 minutes, depending on the manufacturer's instructions). The aim is to thoroughly wet the dust and dried excrement and inactivate the virus.
- Collecting and cleaning afterward: Wipe up the soaked areas with paper towels or a cloth and dispose of both in a tightly sealed plastic bag with household waste. Then thoroughly clean the affected surfaces with a special surface disinfectant according to the instructions for use.
- Alternatively: For smooth surfaces, a solution of commercially available household bleach (sodium hypochlorite) diluted at a ratio of 1:10 (one part bleach, nine parts water) is also effective. For more sensitive surfaces or electronic devices, an alcohol-based disinfectant such as highly concentrated isopropyl alcohol (99.9%), which evaporates without leaving residue, is recommended. However, when cleaning with alcohol, larger areas in an enclosed room should not be left soaking wet; ensure good ventilation and observe fire safety precautions.
- After cleaning: Remove and dispose of the gloves. Wash your hands thoroughly with soap and water. The clothing you wore should be washed immediately.
Important: Apply this method to dead mice and their nests as well. Spray them first, then dispose of them without touching them directly. Always wear gloves when doing so.
Respiratory protection: Choose the right mask for protection
Not every mask protects against viruses. Cloth masks (fabric face coverings) or surgical masks (surgical masks) are primarily designed to protect others by filtering the wearer's droplets. They do not provide sufficient protection against inhaling the smallest virus-containing aerosols, such as those generated when rodent dust is stirred up. The ECDC also explicitly recommends that medical personnel wear FFP2 respirators when caring for suspected ANDV cases.
The only effective protection is a particle-filtering half mask. In the EU, these must be tested according to the EN 149 standard and fall into the FFP2 or FFP3 classes. Their fit creates a tight seal against the face and filters out at least 94 percent (FFP2) or 99 percent (FFP3) of airborne particles up to 0.6 μm in size. Although hantaviruses themselves are smaller, measuring approximately 80–120 nm in diameter, they generally adhere to larger dust particles, which are effectively retained by FFP masks.
For activities involving heavy dust generation, such as in old sheds or stables, an FFP3 mask is recommended. Please ensure a proper fit without leaks, particularly at the sides and around the nose bridge. Unobstructed breathing must be possible. A suitable and tested range of FFP2/FFP3 masks provides protection in all situations. People with beards or certain face shapes should check the seal, as this can impair filtration performance.
Vaccine research: A glimmer of hope on the horizon
The good news is that science is not standing still. The lack of a vaccine is a known problem that is being intensively addressed worldwide.
In Germany and Europe, Puumala virus predominates, but vaccine research is targeting several hantavirus types simultaneously. An international research team from the University of Bath is working on a novel vaccine candidate that uses both mRNA technology and a groundbreaking stabilization method called “ensilication” - the active vaccine components are enclosed in protective silica shells, making refrigeration unnecessary. Preclinical tests have shown excellent immune responses.
Particularly promising: A study published in Nature Communications in March 2026 demonstrated a sophisticated structure-based approach. Researchers developed a genetically stabilized glycoprotein antigen from Hantaan virus, fixed in a prefusion-stabilized conformation. Administered as both a DNA and an mRNA vaccine, it triggered strong and long-lasting production of neutralizing antibodies and protected mice against a lethal dose of hantavirus. The antibodies generated in this way remained at high levels for months, while antibody levels quickly declined after administration of the conventional inactivated vaccine.
Research is also being conducted into a universal vaccine that protects against several hantavirus types at the same time. In South Korea, the Vaccine Innovation Center at Korea University successfully tested an mRNA vaccine against Hantaan and Seoul viruses in animal trials, with the goal of bringing it into phase 1 clinical trials by 2028. A universal vaccine that also covers Andes virus is in the early research stages. In the United States, a DNA vaccine against Andes virus has already been tested in a phase 1 study involving 48 healthy adults - more than 80 percent of those vaccinated retained protective antibody levels for 337 days.
Nevertheless: Several more years will pass before a vaccine is generally available. The rarity and geographical dispersion of cases make large-scale phase 3 efficacy studies difficult, and reliable surrogate markers for accelerated approval procedures are still lacking.
At the same time, European health authorities are focusing on surveillance. During the 2026 ANDV outbreak, the European Centre for Disease Prevention and Control (ECDC) promptly published a threat assessment report and sent an expert from the EU Health Task Force to the affected cruise ship. The EU Health Security Committee (HSC) coordinated the repatriation and quarantine of the passengers. The ECDC assesses the risk to the general population in the EU as very low.
Through the season with knowledge and composure
Hantaviruses are part of our environment, and they will remain so. The outbreak mentioned at the beginning on the “MV Hondius” was a tragic isolated incident caused by the specific characteristics of a virus type not found in Germany. The local authorities, led by the RKI, have emphasized for years and continue to emphasize: There is no reason to panic. The risk to the general population is low and can be controlled almost completely through prudent action.
Protection is not a matter of luck, but of knowledge and proper preparation. Anyone who takes the necessary care in high-risk areas and during high-risk months, wears an FFP2/FFP3 mask, and follows the simple cleaning rules can effectively protect themselves and their family. Vaccine research is making significant progress - from mRNA platforms and DNA vaccines to universal approaches. Until these are ready for the market, however, consistent prevention remains our best protection. Use information provided by reputable sources such as the Robert Koch Institute to stay up to date. Enter the gardening season informed and prepared - and enjoy nature without unnecessary worry.
